Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy (Front. Pharmacol., (2023), 14, 1150270, 10.3389/fphar.2023.1150270)

  • Naveen Kumar Velayutham
  • , Tamilanban Thamaraikani
  • , Shadma Wahab
  • , Mohammad Khalid
  • , Gobinath Ramachawolran
  • , Shahabe Saquib Abullais
  • , Ling Shing Wong
  • , Mahendran Sekar
  • , Siew Hua Gan
  • , Angel Jemima Ebenezer
  • , Mrinalini Ravikumar
  • , Vetriselvan Subramaniyan
  • , Nur Najihah Izzati Mat Rani
  • , Yuan Seng Wu
  • , Srikanth Jeyabalan

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Fingerprint

Dive into the research topics of 'Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy (Front. Pharmacol., (2023), 14, 1150270, 10.3389/fphar.2023.1150270)'. Together they form a unique fingerprint.

Nursing and Health Professions